PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway

Jonathan J. Hodgins(University of Ottawa), Michele Ardolino(University of Ottawa)
The Journal of Experimental Medicine
June 13, 2024
Cited by 10


Related Papers